Literature DB >> 30916190

The Challenges of Controlling Arterial Hypertension in the Elderly.

Marcus Vinicius Bolivar Malachias1,2.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 30916190      PMCID: PMC6424041          DOI: 10.5935/abc.20190020

Source DB:  PubMed          Journal:  Arq Bras Cardiol        ISSN: 0066-782X            Impact factor:   2.000


× No keyword cloud information.
This issue of the “Archives” brings the study “Hypertension Prevalence, Treatment and Control in Older Adults in a Brazilian Capital City”, by Souza ALL et al.,[1] disclosing data about this important cardiovascular risk factor in Goiânia, state of Goiás, Brazil, depicting the situation in our coutry.[1] In this mini-editorial, we review the epidemiology of arterial hypertension (AH) in Brazil and worldwide. AH is the leading preventable cause of premature death.[2] A report by the US Institute of Medicine considers AH as a neglected disease, because it is often overlooked by the population and underestimated by the medical community.[3] Although AH is relatively easy to prevent, simple to diagnose and considerably less expensive to treat, it remains one of the most important causes of death.[4] More than 50% of deaths from coronary artery disease and cerebrovascular accidents in the US occur in individuals with AH.[5] A survey concluded that the estimated global prevalence of AH is increasing.[6] Globally, 31.1% of the adult population had AH in 2010. The prevalence of AH is higher in low- and middle-income countries (31.5%) when compared to high-income countries (28.5%).[6] From 2000 to 2010, the AH prevalence in high-income countries decreased by 2.6%, and awareness, treatment and control substantially improved. However, in low- and middle-income countries, there was an increase in prevalence of 7.7%.[6] However, a more recent analysis showed that the overall prevalence of age-standardized AH was 24.1% in men and 20.1% in women by 2015.[7] The worldwide number of adults with AH increased from 594 million in 1975 to 1.13 billion in 2015, increasing mainly in low- and middle-income countries.[7] In relation to the elderly population, the International Mobility In Aging Study (IMIAS) showed that the prevalence of AH ranged from 53.4% to 83.5% in five assessed cities: Kingston (Canada), Saint-Hyacinthe (Canada), Tirana (Albania), Manizales (Colombia) and Natal (Brazil).[8] More than 2/3 of the hypertensive participants were aware of the diagnosis (of 67.3% in Saint-Hyacinthe to 85.4% in Tirana), especially among women.[8] Although more than 80% of the patients were receiving treatment, the control rates were low: 37.6% in Manizales; 29.5% in Kingston; 26.5% in Saint-Hyacinthe; 24% in Tirana and 22% in Natal, with the Brazilian city showing the least effective disease control.[8] Currently, Canada has the world's best rates of AH control, estimated at 68% of the affected population.[9] That country has achieved a dramatic reduction regarding the lack of diagnosis knowledge (43% in 1991 versus 17% in 2013), with the percentage of patients being treated increasing from 34% to 80% in the same period.[9] The US has shown better AH control in women than in men (55.3% versus 38.0% in 2009-2012); as well as among Whites compared to Blacks and Hispanics (41.3% versus 31.1% and 23.6%).[10] In that country, there is a better AH control among the elderly than in young individuals (50.5%, in adults aged 60 to 70 years, versus 34.4% in patients aged 18 to 39 years in 2011-2012).[11],[12] As for the population aged 75 years or older, there was a slight decline in control (46%), which continues to decline from 80 years onward (39.8%).[12] In Brazil, data from the “Surveillance System for Risk and Protective Factors for Chronic Diseases by Telephone Survey (Vigitel)” (2006 to 2014), indicate that self-reported AH in adults living in capitals ranged from 23% to 25%.[13],[14] Among adults aged 60 to 64 years, the prevalence was 44.4%; in those aged 65 to 74 years, 52.7%; and from 75 years onward, 55%.[13] The rates of knowledge (22% to 77%), treatment (11.4% to 77.5%) and control (10.1% to 35.5%) varied widely, depending on the assessed population.[15] Data from VIGITEL 2017, related to 2016, showed that 60.9% of adults aged 65 years and older reported the diagnosis of AH in a telephone survey.[16] The first Brazilian Registry of AH reveals encouraging data, demonstrating a significant improvement in AH control in the country, when considering the population treated in referral centers.[17] Based on the population treated in 45 centers distributed throughout all Brazilian regions, with a mean age of 61 years, blood pressure (BP) control was observed below 140/90 mmHg in 59.6% of the patients, considering the stabilization of BP in all visits, and 60.6% when considering the measurements in the one-year follow-up consultation.[17] Such rates, however, do not reflect the overall situation of AH control in the country. In the article by Souza ALL et al.,[1] published in this issue, the total prevalence of AH in the assessed elderly was 74.9%, being higher among men (78.6%). The treatment rate was 72.6% and the percentage of AH control was 50.8%, being higher among women.[1] These data show that, although there is still need for improvement, there has been an important increase in the rates of diagnosis, knowledge, treatment and control of AH in our country, especially among the elderly population.
  11 in total

1.  Trends in mortality from all causes and cardiovascular disease among hypertensive and nonhypertensive adults in the United States.

Authors:  Earl S Ford
Journal:  Circulation       Date:  2011-04-26       Impact factor: 29.690

2.  IOM urges more attention by physicians, public on "neglected" hypertension.

Authors:  Mike Mitka
Journal:  JAMA       Date:  2010-04-14       Impact factor: 56.272

3.  Factors associated with hypertension prevalence, awareness, treatment and control among participants in the International Mobility in Aging Study (IMIAS).

Authors:  B Doulougou; F Gomez; B Alvarado; R O Guerra; A Ylli; J Guralnik; M V Zunzunegui
Journal:  J Hum Hypertens       Date:  2015-04-02       Impact factor: 3.012

4.  Hypertension among adults in the United States: National Health and Nutrition Examination Survey, 2011-2012.

Authors:  Tatiana Nwankwo; Sung Sug Yoon; Vicki Burt; Quiping Gu
Journal:  NCHS Data Brief       Date:  2013-10

5.  The First Brazilian Registry of Hypertension.

Authors:  Renato D Lopes; Weimar Kunz Sebba Barroso; Andrea Araujo Brandao; Eduardo Costa Duarte Barbosa; Marcus Vinicius Bolivar Malachias; Marco Mota Gomes; Celso Amodeo; Rui Manoel Dos Santos Povoa; Margaret Assad Cavalcante; Dalton Bertolim Précoma; Antônio Carlos Sobral Sousa; João Miguel Malta Dantas; Evandro José Cesarino; Paulo Cesar B Veiga Jardim
Journal:  Am Heart J       Date:  2018-08-30       Impact factor: 4.749

6.  A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010.

Authors:  Stephen S Lim; Theo Vos; Abraham D Flaxman; Goodarz Danaei; Kenji Shibuya; Heather Adair-Rohani; Markus Amann; H Ross Anderson; Kathryn G Andrews; Martin Aryee; Charles Atkinson; Loraine J Bacchus; Adil N Bahalim; Kalpana Balakrishnan; John Balmes; Suzanne Barker-Collo; Amanda Baxter; Michelle L Bell; Jed D Blore; Fiona Blyth; Carissa Bonner; Guilherme Borges; Rupert Bourne; Michel Boussinesq; Michael Brauer; Peter Brooks; Nigel G Bruce; Bert Brunekreef; Claire Bryan-Hancock; Chiara Bucello; Rachelle Buchbinder; Fiona Bull; Richard T Burnett; Tim E Byers; Bianca Calabria; Jonathan Carapetis; Emily Carnahan; Zoe Chafe; Fiona Charlson; Honglei Chen; Jian Shen Chen; Andrew Tai-Ann Cheng; Jennifer Christine Child; Aaron Cohen; K Ellicott Colson; Benjamin C Cowie; Sarah Darby; Susan Darling; Adrian Davis; Louisa Degenhardt; Frank Dentener; Don C Des Jarlais; Karen Devries; Mukesh Dherani; Eric L Ding; E Ray Dorsey; Tim Driscoll; Karen Edmond; Suad Eltahir Ali; Rebecca E Engell; Patricia J Erwin; Saman Fahimi; Gail Falder; Farshad Farzadfar; Alize Ferrari; Mariel M Finucane; Seth Flaxman; Francis Gerry R Fowkes; Greg Freedman; Michael K Freeman; Emmanuela Gakidou; Santu Ghosh; Edward Giovannucci; Gerhard Gmel; Kathryn Graham; Rebecca Grainger; Bridget Grant; David Gunnell; Hialy R Gutierrez; Wayne Hall; Hans W Hoek; Anthony Hogan; H Dean Hosgood; Damian Hoy; Howard Hu; Bryan J Hubbell; Sally J Hutchings; Sydney E Ibeanusi; Gemma L Jacklyn; Rashmi Jasrasaria; Jost B Jonas; Haidong Kan; John A Kanis; Nicholas Kassebaum; Norito Kawakami; Young-Ho Khang; Shahab Khatibzadeh; Jon-Paul Khoo; Cindy Kok; Francine Laden; Ratilal Lalloo; Qing Lan; Tim Lathlean; Janet L Leasher; James Leigh; Yang Li; John Kent Lin; Steven E Lipshultz; Stephanie London; Rafael Lozano; Yuan Lu; Joelle Mak; Reza Malekzadeh; Leslie Mallinger; Wagner Marcenes; Lyn March; Robin Marks; Randall Martin; Paul McGale; John McGrath; Sumi Mehta; George A Mensah; Tony R Merriman; Renata Micha; Catherine Michaud; Vinod Mishra; Khayriyyah Mohd Hanafiah; Ali A Mokdad; Lidia Morawska; Dariush Mozaffarian; Tasha Murphy; Mohsen Naghavi; Bruce Neal; Paul K Nelson; Joan Miquel Nolla; Rosana Norman; Casey Olives; Saad B Omer; Jessica Orchard; Richard Osborne; Bart Ostro; Andrew Page; Kiran D Pandey; Charles D H Parry; Erin Passmore; Jayadeep Patra; Neil Pearce; Pamela M Pelizzari; Max Petzold; Michael R Phillips; Dan Pope; C Arden Pope; John Powles; Mayuree Rao; Homie Razavi; Eva A Rehfuess; Jürgen T Rehm; Beate Ritz; Frederick P Rivara; Thomas Roberts; Carolyn Robinson; Jose A Rodriguez-Portales; Isabelle Romieu; Robin Room; Lisa C Rosenfeld; Ananya Roy; Lesley Rushton; Joshua A Salomon; Uchechukwu Sampson; Lidia Sanchez-Riera; Ella Sanman; Amir Sapkota; Soraya Seedat; Peilin Shi; Kevin Shield; Rupak Shivakoti; Gitanjali M Singh; David A Sleet; Emma Smith; Kirk R Smith; Nicolas J C Stapelberg; Kyle Steenland; Heidi Stöckl; Lars Jacob Stovner; Kurt Straif; Lahn Straney; George D Thurston; Jimmy H Tran; Rita Van Dingenen; Aaron van Donkelaar; J Lennert Veerman; Lakshmi Vijayakumar; Robert Weintraub; Myrna M Weissman; Richard A White; Harvey Whiteford; Steven T Wiersma; James D Wilkinson; Hywel C Williams; Warwick Williams; Nicholas Wilson; Anthony D Woolf; Paul Yip; Jan M Zielinski; Alan D Lopez; Christopher J L Murray; Majid Ezzati; Mohammad A AlMazroa; Ziad A Memish
Journal:  Lancet       Date:  2012-12-15       Impact factor: 79.321

Review 7.  Hypertension in Canada: Past, Present, and Future.

Authors:  Ernesto L Schiffrin; Norman R C Campbell; Ross D Feldman; Janusz Kaczorowski; Richard Lewanczuk; Raj Padwal; Sheldon W Tobe
Journal:  Ann Glob Health       Date:  2016 Mar-Apr       Impact factor: 2.462

8.  Worldwide trends in blood pressure from 1975 to 2015: a pooled analysis of 1479 population-based measurement studies with 19·1 million participants.

Authors: 
Journal:  Lancet       Date:  2016-11-16       Impact factor: 79.321

9.  7th Brazilian Guideline of Arterial Hypertension: Chapter 1 - Concept, Epidemiology and Primary Prevention

Authors:  Mvb Malachias; F L Plavnik; C A Machado; D Malta; L C N Scala; S Fuchs
Journal:  Arq Bras Cardiol       Date:  2016-09       Impact factor: 2.000

10.  Trends in hypertension prevalence, awareness, treatment, and control among US adults 80 years and older, 1988-2010.

Authors:  Samantha G Bromfield; C Barrett Bowling; Rikki M Tanner; Carmen A Peralta; Michelle C Odden; Suzanne Oparil; Paul Muntner
Journal:  J Clin Hypertens (Greenwich)       Date:  2014-03-12       Impact factor: 3.738

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.